Setareh van Driel Shamsili
Nessuna posizione attualmente
Profilo
Setareh van Driel Shamsili served as the Chief Medical Officer & Senior Vice President at Merus NV from 2012 to 2016.
He also worked as the Global Medical Leader-Oncology at Astellas Pharma Global Development, Inc. He later became the Chief Medical Officer at Ryvu Therapeutics SA from 2019 to 2022.
Dr. van Driel Shamsili holds a doctorate degree from Erasmus University Rotterdam and a graduate degree from Tehran University of Medical Sciences.
Precedenti posizioni note di Setareh van Driel Shamsili
| Società | Posizione | Fine |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Direttore Tecnico/Scientifico/R&S | 01/02/2022 |
| MERUS N.V. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formazione di Setareh van Driel Shamsili
| Erasmus University Rotterdam | Doctorate Degree |
| Tehran University of Medical Sciences | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERUS N.V. | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| Aziende private | 1 |
|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
- Borsa valori
- Insiders
- Setareh van Driel Shamsili
